Search results
Showing 1 to 15 of 55 results for ng191
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
Dexamethasone and hydrocortisone are both corticosteroids; they have a role in treating COVID-19 in certain people.
COVID-19 (NG191). This example was originally submitted to demonstrate implementation of NG163. This guidance has been updated and...
implementation of NG163. This guidance has been updated and replaced by NG191 for managing COVID-19. The submission has been reviewed...
Managing COVID symptoms (including at the end of life) in a prison setting
implementation of NG163. This guidance has been updated and replaced by NG191 for managing COVID-19. The submission has been reviewed...
Recommendation ID NG191/13 Question What are the views, preferences and experiences of people with COVID-19-associated pulmonary...
Recommendation ID NG191/6 Question Does a multidisciplinary team agreed approach to weaning from continuous positive airway pressure...
Recommendation ID NG191/7 Question What is the effectiveness, cost effectiveness and safety of using a combination of casirivimab and...
Recommendation ID NG191/9 Question What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in
Recommendation ID NG191/3 Question What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs)
Recommendation ID NG191/4 Question Does early review and referral to specialist palliative care services improve outcomes for adults with
Recommendation ID NG191/10 Question What risk factors in people who are critically ill and have, or have had, COVID-19 as part of their
Recommendation ID NG191/2 Question What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE)...
Recommendation ID NG191/15 Question What is the effectiveness and safety of neutralising monoclonal antibodies against different...
Recommendation ID NG191/5 Question Is high-flow nasal oxygen effective in reducing breathlessness compared with standard care or...